Company Directory - Research & Development
MedAustron in Wiener Neustadt, Austria, is one of the world’s most cutting-edge centers for cancer treatment and research. It started treating patients in Dezember 2016. MedAustron uses an innovative form of radiation therapy, namely ion beam therapy. Patients get irradiated with charged particles – protons or carbon ions.
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm supports clients in mitigating development risks, creating data packages more likely to attract investors and support submissions that inspire regulators’ confidence.
MMV is a leading product development partnership (PDP) in antimalarial drug research. Its mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and delivering new, effective and affordable antimalarial drugs.
Medigene is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. With its scientific expertise, Medigene is working on the development of innovative immunotherapies to treat cancer such as T cell receptor-modified T cells (TCR‑Ts) or dendritic cell (DC) vaccines in fields of high medical need.
In its 10 Research & Development centers, Menarini’s main focus is dedicated to therapeutic areas with unresolved pathologies, such as oncology and anti-infectives (AMR), where increasing treatment options is fundamental to helping those in need.
For 130 years, Merck (known as MSD outside of the U.S. and Canada) has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives.
We are here for people at every step, helping to create, im-prove and prolong life. We deliver personalized treatments for serious diseases and enable people to achieve their dream of becoming parents. We empower the scientific community.
The Metrion team has substantial experience of providing high quality drug discovery services for ion channel targets to clients on a fee-for-service or collaboration basis. Metrion is also a leading provider of cardiac safety profiling, cardiac translational assays and neuronal translational assays.
Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients.
As our name indicates, collaboration is in our DNA: within our team, with our partners, and with patients and providers. We build on deep trust, individual diversity, and shared passion to reach our common goal of surmounting the toughest challenges in medicine, including the treatment of cancer and other serious diseases.
Murdoch Children's Research Institute (MCRI) is the largest child health research institute in Australia and one of the top three worldwide for research quality and impact*. Our team of more than 1200 talented researchers is dedicated to making discoveries to prevent and treat childhood conditions.
Myricx Pharma (“Myricx”) is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across viral and other diseases.
Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to reduce clinical attrition and enhance their molecules formulation performance through its best-in-class nanonization™ services.
Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four leading-edge neuroscientists and stem cell pioneers at The University of California, San Francisco. We are focused on the discovery and development of cell-based therapies to treat intractable neurological disease.
